Meeting
2017 Genitourinary Cancers Symposium
Phase I/II study on stereotactic hypofractionated once-weekly radiation therapy (SHORT) for localized prostate cancer.
Authors
Indranil Mallick
Tata Medical Center, Kolkata, India
Indranil Mallick , Moses Arunsingh , Sriram Prasath , B Arun , Paromita Roy , Deepak Dabkara , Sujoy Gupta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Prostate Cancer,Urothelial Carcinoma,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Clinical Trial Registration Number
CTRI/2016/02/006671
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 130)
DOI
10.1200/JCO.2017.35.6_suppl.130
Abstract #
130
Poster Bd #
B24
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcomes for 854 consecutive patients treated over 10 years (70 Gy in 2.5 Gy/fraction).
First Author: Omar Y. Mian
Poster
2014 Genitourinary Cancers Symposium
Long-term clinical and toxicity outcomes of hypofractionated intensity-modulated radiation therapy for clinically localized prostate cancer.
First Author: Rupesh Kotecha
Poster
2024 ASCO Genitourinary Cancers Symposium
Relugolix versus leuprolide in combination with radiotherapy for localized prostate cancer (REVELUTION trial): An initial analysis of patient treatment preferences and quality of life.
First Author: Sagar A. Patel
Poster
2024 ASCO Genitourinary Cancers Symposium
Pretreatment colonoscopy impact on acute gastrointestinal (GI) toxicity following curative stereotactic body radiation therapy (SBRT) for localized prostate cancer.
First Author: Jonathan W. Lischalk